ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag quotes science policy

What Budget Cuts Might Mean for US Science
Diana Kwon | Mar 21, 2017 | 5 min read
A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  
Genome Investigator Craig Venter Reflects On Turbulent Past And Future Ambitions
Karen Young Kreeger | Jul 23, 1995 | 8 min read
And Future Ambitions Editor's Note: For the past four years, former National Institutes of Health researcher J. Craig Venter has been a major figure in the turbulent debates and scientific discoveries surrounding the study of genes and genomes. Events heated up in 1991, when NIH attempted to patent gene fragments, which were isolated using Venter's expressed sequence tag (EST)/complementary DNA (cDNA) approach for discovering human genes (M.A. Adams et al., Science, 252:1651-6, 1991). NIH's mo
Top 10 Innovations 2016
The Scientist | Dec 1, 2016 | 10+ min read
This year’s list of winners celebrates both large leaps and small (but important) steps in life science technology.
Senior Scientists Quit Europe
Silvia Sanides | Jun 1, 2003 | 7 min read
©Paul Barton, Corbis Rigid retirement policies are prompting scientists to flee Europe at the height of their professional lives to start second careers in the United States. Many of these researchers are still conducting experiments and are in no mood to slow down. But because nearly all European universities are government run, professors are left little choice when they reach mandatory retirement age, which in most countries is 65 years or even younger. Some scientists leaving for the
Of Cells and Limits
Anna Azvolinsky | Mar 1, 2015 | 9 min read
Leonard Hayflick has been unafraid to speak his mind, whether it is to upend a well-entrenched dogma or to challenge the federal government. At 86, he’s nowhere near retirement.
Notebook
The Scientist Staff | Mar 2, 1997 | 8 min read
Monday mornings can be tough, even if you're Bill Gates. The head of Redmond, Wash.-based Microsoft Corp. ran into a few glitches at a presentation he was giving at the annual meeting of the American Association for the Advancement of Science (AAAS) in Seattle. In the middle of a demonstration on February 17 aimed at showing how Web browsers and E-mail will soon merge, the modem connection failed. A computer-vision demonstration by a Microsoft researcher didn't work, either. Then, during a ques
Toward a “Clickable Plant”
Jane Salodof Macneil | Feb 15, 2004 | 9 min read
By conscious design, plant genomics initiatives have devoted initial resources to new technology development. Part of that money went to developing functional genomics approaches, and part to new sequencing technologies.
'Consensus Statement' Fails To Capture Attention In Washington, D.C.
Barbara Spector | Sep 18, 1994 | 6 min read
At the same time, he and other framers of the statement say they are gratified that so many diverse and prestigious organizations have put their support behind the effort. "I guess I had hoped that more congressional offices and more parts of the [Clinton] administration would have taken note of the breadth of the constituents that had thought it important to prepare a statement," says Leon Rosenberg, president of the Bristol-Myers
'Consensus Statement' Fails To Capture Attention In Washington, D.C.
Barbara Spector | Sep 18, 1994 | 6 min read
At the same time, he and other framers of the statement say they are gratified that so many diverse and prestigious organizations have put their support behind the effort. "I guess I had hoped that more congressional offices and more parts of the [Clinton] administration would have taken note of the breadth of the constituents that had thought it important to prepare a statement," says Leon Rosenberg, president of the Bristol-Myers
Universities Beg For Cash To Repair Crumbling Labs
The Scientist Staff | Sep 3, 1989 | 5 min read
WASHINGTON—Everybody seems eager to see a federally sponsored academic research facilities program. But no one seems to know how to fund it. The lack of consensus on how the United States government would finance the rejuvenation of aging university laboratories has led to conflicting advice from traditional allies, mixed signals from the Bush administration, and a scatter-shot approach by Congress. As a result, the chances appear slim that any such program will get off the ground this

Run a Search

ADVERTISEMENT